-
|
Business Wire –
4:05 PM ET 01/12/2021
Healthcare Industry Veteran Brings Digital Health Expertise and Consumer-Centric Approach to Furthering Companys Mission of Transforming Dialysis Treatment Outset Medical, Inc. (OM) , a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, is bolstering its board of directors with the appointment of Karen Drexler.
|
-
|
Business Wire –
4:05 PM ET 01/07/2021
ResMed (RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2021 on Thursday, January 28, 2021, after the New York Stock Exchange closes. Earnings webcast details: Please note that ResMed (RMD) does not use outside phone lines to access the earnings call.
|
-
|
Business Wire –
9:00 AM ET 01/05/2021
ResMed (RMD) today announced Mick Farrell, chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, beginning at approximately 4:30 p.m. via webcast.
|
-
|
Business Wire –
4:05 PM ET 12/14/2020
Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Rajwant Singh Sodhi as an independent member of its board of directors effective January 1, 2021. We are pleased to welcome Raj to our Board of Directors at this important next stage of Tandems evolution, said John Sheridan, president and chief executive officer.
|
-
|
Business Wire –
12:06 AM ET 11/05/2020
The digital campaign will educate consumers and doctors on sleep disorders ResMed (RMD), a global leader in digital health and connected sleep and respiratory care devices, today announced the launch of a new sleep education campaign, #WakeUpToGoodSleep.
|
-
|
Business Wire –
9:00 AM ET 11/03/2020
ResMed (RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 29th Annual Global Healthcare Conference on Tuesday, November 10, 2020, beginning at approximately 5:00 p.m. via video webcast.
|
-
|
Reuters –
5:19 PM ET 10/29/2020
Resmed Inc (RMD): * . ANNOUNCES RESULTS FOR THE FIRST QUARTER OF FISCAL YEAR 2021. * Q1 NON-GAAP EARNINGS PER SHARE $1.27. * Q1 GAAP EARNINGS PER SHARE $1.22. * Q1 REVENUE $751.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF $710.7 MILLION. * Q1 EARNINGS PER SHARE ESTIMATE $1.03 -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:
|
-
|
Business Wire –
4:05 PM ET 10/29/2020
Year-over-year revenue grows 10%, non-GAAP operating profit up 24% Note: A webcast of ResMeds conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO---- ResMed Inc. (RMD), a world-leading digital health company, today announced results for its quarter ended September 30, 2020.
|
Page:
|
Today's and Upcoming Events
-
RMD to announce Q2 earnings (Confirmed)
Past Events (last 90 days)
-
RMD ex-Dividend for $0.39 on 11/10/2020
- Announce Date: 10/29/2020
- Record Date: 11/12/2020
- Pay Date: 12/17/2020
-
RMD announced Q1 earnings.
Data provided by Thomson Reuters © 2021
|